BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3410494)

  • 1. Chemotactic factor-induced polarization, receptor redistribution, and locomotion of human blood monocytes.
    Islam LN; Wilkinson PC
    Immunology; 1988 Jul; 64(3):501-7. PubMed ID: 3410494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
    Doherty DE; Haslett C; Tonnesen MG; Henson PM
    J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human C5a modulates monocyte Fc and C3 receptor expression.
    Yancey KB; O'Shea J; Chused T; Brown E; Takahashi T; Frank MM; Lawley TJ
    J Immunol; 1985 Jul; 135(1):465-70. PubMed ID: 3158706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of chemotactic ligand receptors on human peripheral blood monocytes.
    Ohura K; Katona IM; Wahl LM; Chenoweth DE; Wahl SM
    J Immunol; 1987 Apr; 138(8):2633-9. PubMed ID: 2435802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time dependence of transmembrane potential changes and intracellular calcium flux in stimulated human monocytes.
    Bernardo J; Brink HF; Simons ER
    J Cell Physiol; 1988 Jan; 134(1):131-6. PubMed ID: 2826501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients.
    Girasole G; Wang JM; Pedrazzoni M; Pioli G; Balotta C; Passeri M; Lazzarin A; Ridolfo A; Mantovani A
    J Immunol; 1990 Oct; 145(8):2459-64. PubMed ID: 2212648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relations between Fc receptor function and locomotion in human lymphocytes.
    Shields JM; Wilkinson PC
    Clin Exp Immunol; 1979 Dec; 38(3):598-608. PubMed ID: 119597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants.
    Cianciolo GJ; Snyderman R
    J Clin Invest; 1981 Jan; 67(1):60-8. PubMed ID: 7451658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chemotactic agents on the locomotion of equine polymorphonuclear and mononuclear leucocytes.
    Sedgwick AD; Dawson J; Lees P
    Res Vet Sci; 1987 Jul; 43(1):55-8. PubMed ID: 3628984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for monocyte isolation and chemotaxis.
    Antrum RM; Solomkin JS
    J Clin Lab Immunol; 1986 Mar; 19(3):139-42. PubMed ID: 3712418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants.
    Glass EJ; Kay AB
    Clin Exp Immunol; 1980 Mar; 39(3):768-75. PubMed ID: 7379336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
    Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
    J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of formyl peptide receptor expression by IL-10 in human monocytes and neutrophils.
    Thivierge M; Parent JL; Stankova J; Rola-Pleszczynski M
    J Immunol; 1999 Mar; 162(6):3590-5. PubMed ID: 10092818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor.
    Yang KH; Fang H; Ye JS; Gong JZ; Wang JT; Xu WF
    Pharmazie; 2008 Nov; 63(11):779-83. PubMed ID: 19069235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of human complement receptors CR1 and CR3: expression of these molecules on monocytes and neutrophils from maternal, newborn and fetal samples.
    Adinolfi M; Cheetham M; Lee T; Rodin A
    Eur J Immunol; 1988 Apr; 18(4):565-9. PubMed ID: 2835247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of a novel neutrophil chemotactic factor derived from human monocytes.
    Kownatzki E; Uhrich S; Grüninger G
    Immunobiology; 1988 Sep; 177(4-5):352-62. PubMed ID: 2848760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.